Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Chronic lymphocytic leukemia evaluation

E. Therapeutic response The safety and efficacy of Campath were evaluated in an open-label study of 93 patients with B-cell chronic lymphocytic leukemia (B-CLL). A partial response was observed in 31% of patients and a complete response in 2%. The median duration of response was 7 months. [Pg.300]

See other pages where Chronic lymphocytic leukemia evaluation is mentioned: [Pg.18]    [Pg.186]    [Pg.157]    [Pg.392]    [Pg.69]    [Pg.196]    [Pg.338]    [Pg.274]    [Pg.44]    [Pg.470]   
See also in sourсe #XX -- [ Pg.2522 ]



SEARCH



Chronic lymphocytic leukemia

Leukemia chronic

Lymphocyte leukemia

Lymphocytic leukemia

© 2024 chempedia.info